Montreal, February 27, 2026 – A group of MyCBDR users will have received an email in recent days inviting them to complete the PROBE survey....
The CHS has produced a new podcast series entitled NOVEL THERAPIES FOR BLEEDING DISORDERS. The series explores therapies that are potentially coming to the Canadian...
Montreal, February 5, 2026 – Four Canadian bleeding disorder treatment centres are participating in the Phase 1 clinical trial of Regeneron’s CRISPR/Cas9-based targeted gene insertion...
Coproduced by the Canadian Hemophilia Society and the Irish Haemophilia Society, two new podcasts discussing hemophilia gene therapy have been released! These are part of...
Montréal, December 17, 2025 – The Canadian Hemophilia Society (CHS) has written to the Provincial/Territorial Ministers of Health (excluding Quebec) to urge them to add...